LUCINDA HEFNER: Open Payments
NPI 1306464565 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 20 payments from 11 companies in 2025. Trend: 2023 $93 · 2024 $164 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $159 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| Supernus Pharmaceuticals, Inc. | 4 | $71 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Alkermes, Inc. | 1 | $23 |
| Braeburn Inc. | 1 | $20 |
| Corium, LLC | 1 | $20 |
Products named: COBENFY, ABILIFY ASIMTUFII, Qelbree, UZEDY, REXULTI, INGREZZA, HETLIOZ, ARISTADA.
Industry payments across TN — which companies pay providers there.
